These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25425437)

  • 1. Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis.
    Siriopol D; Hogas S; Veisa G; Mititiuc I; Volovat C; Apetrii M; Onofriescu M; Busila I; Oleniuc M; Covic A
    Int Urol Nephrol; 2015 Mar; 47(3):563-9. PubMed ID: 25425437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.
    Jiang J; Chen P; Chen J; Yu X; Xie D; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Zhang P; Yang X; Zhang Y; Zhang Y; Liang X; Zhang Z; Lin Q; Yu Y; Miyata T; Tian J; Liang M; Luo W; Xu X; Hou F
    Atherosclerosis; 2012 Sep; 224(1):187-94. PubMed ID: 22857897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
    Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
    Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients.
    Arsov S; Trajceska L; van Oeveren W; Smit AJ; Dzekova P; Stegmayr B; Sikole A; Rakhorst G; Graaff R
    Artif Organs; 2013 Jul; 37(7):E114-22. PubMed ID: 23635017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis.
    Jiang J; Zhang Y; Chen J; Yang X; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Zhang P; Zhang Y; Zhang Y; Liu S; Zhang Z; Lin Q; Yu Y; Tian J; Luo W; Qin X; Hou FF
    Am J Nephrol; 2021; 52(1):8-16. PubMed ID: 33596571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?
    Koc Y; Unsal A; Basturk T; Sakaci T; Ahbap-Dal E; Sinangil-Arar A; Kose-Budak S; Kayabasi H
    Nefrologia; 2012 May; 32(3):335-42. PubMed ID: 22508142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of advanced glycation end products accumulation, using skin autofluorescence, in CKD and dialysis patients.
    Oleniuc M; Schiller A; Secara I; Onofriescu M; Hogas S; Apetrii M; Siriopol D; Covic A
    Int Urol Nephrol; 2012 Oct; 44(5):1441-9. PubMed ID: 22160646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of peritoneal dialysis with hemodialysis on survival of diabetic patients with end-stage kidney disease: a meta-analysis of cohort studies.
    Xue J; Li H; Zhou Q; Wen S; Zhou Q; Chen W
    Ren Fail; 2019 Nov; 41(1):521-531. PubMed ID: 31216914
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of initial dialysis modality on mortality: a propensity-matched study.
    Waldum-Grevbo B; Leivestad T; Reisæter AV; Os I
    BMC Nephrol; 2015 Oct; 16():179. PubMed ID: 26519164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of furosine and pentosidine in CAPD patients.
    Kumano K; Yokota S; Sakai T; Kobayashi N; Yoshida A; Yoshihara T; Shibata K; Izumi G; Wang H
    Adv Perit Dial; 1997; 13():53-7. PubMed ID: 9360651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review.
    Arsov S; Graaff R; van Oeveren W; Stegmayr B; Sikole A; Rakhorst G; Smit AJ
    Clin Chem Lab Med; 2014 Jan; 52(1):11-20. PubMed ID: 23612551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.
    Hartog JW; Hummel YM; Voors AA; Schalkwijk CG; Miyata T; Huisman RM; Smit AJ; Van Veldhuisen DJ
    J Card Fail; 2008 Sep; 14(7):596-602. PubMed ID: 18722326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality: is it fair to compare PD & HD?
    Nolph K
    Nephrol News Issues; 1996 Feb; 10(2):14. PubMed ID: 8709990
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes mellitus and dialysis.
    Stein G; Fünfstück R; Schiel R
    Minerva Urol Nefrol; 2004 Sep; 56(3):289-303. PubMed ID: 15467507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin autofluorescence is a predictor of cardiovascular disease in chronic kidney disease patients.
    Furuya F; Shimura H; Takahashi K; Akiyama D; Motosugi A; Ikegishi Y; Haraguchi K; Kobayashi T
    Ther Apher Dial; 2015 Feb; 19(1):40-4. PubMed ID: 25545539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients.
    Nongnuch A; Davenport A
    Nephrology (Carlton); 2015 Nov; 20(11):862-7. PubMed ID: 26014842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis in diabetic patients.
    Passadakis P; Oreopoulos D
    Adv Ren Replace Ther; 2001 Jan; 8(1):22-41. PubMed ID: 11172325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy as a cause of end-stage renal disease in Tabuk area, Saudi Arabia: a four-year study.
    El Minshawy O; Ghabrah T; El Bassuoni E
    Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):1105-9. PubMed ID: 25193923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue advanced glycation end product deposition after kidney transplantation.
    Crowley LE; Johnson CP; McIntyre N; Fluck RJ; McIntyre CW; Taal MW; Leung JC
    Nephron Clin Pract; 2013; 124(1-2):54-9. PubMed ID: 24135496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.